Virginia Commonwealth University
Richmond, Virginia, 23298, United States
Location status: Recruiting
NCT Number: NCT04916327
The purpose of this research study is to examine the role oxidants, substances produced in the blood that can damage blood vessel function, may play in blood vessel function in healthy individuals as well as individuals with mental health disorders (posttraumatic stress disorder (PTSD) and/or generalized anxiety disorder (GAD)).
Interested in participating?
Request Info18 year–35 year
All sexes
Interventional
Not applicable
Richmond, Virginia, 23298, United States
Location status: Recruiting
Study #1 is made up of three sessions done on three separate days and the entire study can be completed in as little as two weeks. All testing sessions will take place at the Exercise Physiology Research Laboratory. Volunteers will be asked to participate in one initial testing session (Visit 1) lasting < 1 hour that will help make them more familiar with the study equipment and procedures, determine body measures (height, weight, body fat), determine the maximum strength of their forearm and calf, and require one blood draw. The following two testing sessions (Visits 2 and 3) with each session lasting between 2-3 hours that will involve multiple tests designed to determine the health of their blood vessels. For Visit #2 they will be randomly given either antioxidant pills or placebo pills to determine the effect of oxidants on blood vessel health. For Visit #3, they will be given whatever set of pills (antioxidant or placebo) that they did not receive during Visit #2.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will ingest an antioxidant cocktail containing 800 milligrams of alpha lipoic acid, 1 gram of vitamin C (ascorbic acid), and 400 milligrams of vitamin E (alpha tocopherol).
Subjects will ingest placebo (microcrystalline cellulose) pills.
Time frame: Baseline to the end of the final visit, about 2 weeks
Change in Brachial Artery Dilation from Baseline Values
Time frame: Baseline to the end of the final visit, about 2 weeks
Change in Leg Blood Flow Values from Baseline
Time frame: Baseline to the end of the final visit, about 2 weeks
Change in Brachial Artery Dilation from Baseline Values
Contact information is provided by the study sponsor or research team.
Virginia Commonwealth University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04916340
Cardiovascular Diseases, Mental Disorders
Richmond, Virginia, United States
View Trial DetailsNCT04922762
Cardiovascular Diseases, Mental Disorders
Richmond, Virginia, United States
View Trial DetailsNCT06626646
Arterial Occlusive Diseases, Arteriosclerosis
North York, Ontario, Canada
View Trial DetailsNCT03898570
Arterial Occlusive Diseases, Arteriosclerosis
Palo Alto, California, United States
View Trial Details